New data on efficacy of valacyclovir in secondary prevention of maternal–fetal transmission of cytomegalovirus

Abstract

Our findings indicate that VCV treatment of pregnant women with primary CMV infection reduces the risk of maternal-fetal transmission of CMV and may be effective in cases with primary infection in the first and second trimesters. © 2022 International Society of Ultrasound in Obstetrics and Gynecology.